There is a growing body of evidence supporting the therapeutic potential of CBD for Lupus patients. Lupus is a chronic inflammatory disease that affects nearly every part of the body. It is caused by an autoimmune process, which results in abnormal antibodies attacking healthy human cells. The body’s response to inflammation is complex and involves immune cells, tissue cells, and signaling molecules. CBD has been shown to significantly reduce inflammation in Lupus patients.
Symptoms associated with Lupus include joint pain, fatigue, and fever. Lupus also causes a decreased blood flow to the heart and can affect the brain. In the long term, this disease can lead to high blood pressure, increased risk of infections, and damage to the heart, kidneys, and blood vessels.
A multi-site randomized clinical trial has been launched by Dr. Koumpouras and is designed to enroll 100 patients with lupus. This trial involves the use of a synthetic cannabinoid called Lenabasum, which binds preferentially to CB2 receptors. The drug is designed to reduce inflammatory immune components and ease pain in lupus patients. Participants will take Lenabasum for almost three months, during which they will be monitored for inflammation and pain levels. The study is expected to conclude in early 2019.
Although there is no definitive scientific proof for the effectiveness of CBD oil for Lupus, many people with the disease have found it to be a helpful remedy. While the drug will not cure the disease, it will greatly improve symptoms and improve daily life.